South & Central America Microbiology CRO Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The South & Central America microbiology Contract Research Organization (CRO) services market is projected to grow significantly, reaching an estimated US$ 336.05 million by 2031, up from US$ 196.29 million in 2023. This growth represents a compound annual growth rate (CAGR) of 7.0% from 2023 to 2031.

Executive Summary and Market Analysis

The microbiology CRO services market in South & Central America is primarily divided into three regions: Brazil, Argentina, and the Rest of South and Central America. This region plays a crucial role in the microbiology CRO services sector and is anticipated to experience strong growth throughout the forecast period. Key factors driving this growth include an increase in clinical trials, advancements in clinical trial methodologies by pharmaceutical companies, and supportive government initiatives aimed at facilitating clinical research.

Market Segmentation Analysis

The South & Central America microbiology CRO services market can be analyzed through various segments, including application, service type, microorganisms, and end users:

1. Application: The market is categorized into clinical, medical device, and other applications. In 2023, the clinical segment held the largest market share.

2. Service Type: This market is segmented into assay development, custom viral stock production, microbial testing, and others. The microbial testing segment was the largest contributor to the market in 2023.

3. Microorganisms: The market is further divided based on microorganisms into bacteria, fungi, viruses, and parasites. Bacteria represented the largest share in 2023.

4. End User: The end-user segmentation includes biotech and pharmaceutical companies, medical device companies, and others. In 2023, biotech and pharmaceutical companies dominated this segment.

Market Outlook

The landscape of microbiology CRO services is evolving, with many microbial testing service providers forming partnerships to enhance their service offerings. Notably, there has been a surge in partnership activities in 2022 and 2023, focusing on acquisitions, manufacturing agreements, and product development, driven by the increasing demand for biopharmaceuticals. For instance, in August 2023, Frontage Laboratories, Inc. and its subsidiary Frontage Canada, Inc. acquired Nucro-Technics Inc., a CRO that provides a range of services. Similarly, NAMSA, a prominent MedTech CRO, acquired Perfectus Biomed Group in October 2022, which expanded its reach and capabilities in microbiological services across multiple regions.

These strategic partnerships and collaborations are expected to foster innovation and introduce new trends in the microbiology CRO market in the upcoming years.

Country Insights

The South & Central America microbiology CRO services market is primarily composed of Brazil, Argentina, and the Rest of South & Central America, with Brazil holding the largest market share in 2023. Brazil is a key hub for clinical trials, accounting for 1.7% of global clinical trial activities as of 2021, according to Clinical Trials Arena. In July 2022, Boston CRO acquired the Instituto Brasil de Pesquisa Clinica (IBPClin) in Rio de Janeiro, marking a significant step towards implementing a decentralized clinical trial model in Latin America. IBPClin has conducted over 160 industry-sponsored studies, involving more than 7,000 participants across 12 Brazilian states. Given that microbiological testing is essential in clinical trials, the rising number of clinical trials and the increasing outsourcing of research and development in Brazil are expected to drive growth in the microbiology CRO services market.

Company Profiles

Key players in the microbiology CRO services market include Microbiologics, Melbec Microbiology, Emery Pharma, TheraIndx Lifesciences Pvt. Ltd., AVERIN BIOTECH, Statens Serum Institut, ImQuest BioSciences, PACIFIC BIOLABS, Innovotech Inc., and BluTest Laboratories Ltd. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase their market presence.

Product Code: BMIRE00032145

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. South & Central America Microbiology CRO Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Practice of Outsourcing Clinical Studies with Massive Number of Trials
- 4.1.2 Surging Research and Development Investments
4.2 Market Restraints
- 4.2.1 Shortage of Skilled Professionals
4.3 Market Opportunities
- 4.3.1 Advancements in Microbiology Testing Technology
4.4 Future Trends
- 4.4.1 Rise in Partnerships and Collaborations with Service Providers
4.5 Impact of Drivers and Restraints:

5. Microbiology CRO Market - South & Central America Analysis

5.1 South & Central America Microbiology CRO Market Revenue (US$ Million), 2021-2031
5.2 South & Central America Microbiology CRO Market Forecast Analysis

6. South & Central America Microbiology CRO Market Analysis - by Application

6.1 Clinical
- 6.1.1 Overview
- 6.1.2 Clinical: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Medical Device
- 6.2.1 Overview
- 6.2.2 Medical Device: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.3 Others
- 6.3.1 Overview
- 6.3.2 Others: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. South & Central America Microbiology CRO Market Analysis - by Service Type

7.1 Assay Development
- 7.1.1 Overview
- 7.1.2 Assay Development: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Custom Viral Stock Production
- 7.2.1 Overview
- 7.2.2 Custom Viral Stock Production: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Microbial Testing
- 7.3.1 Overview
- 7.3.2 Microbial Testing: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Microbiology CRO Market Analysis - by Microorganisms

8.1 Bacteria
- 8.1.1 Overview
- 8.1.2 Bacteria: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Fungi
- 8.2.1 Overview
- 8.2.2 Fungi: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Viruses
- 8.3.1 Overview
- 8.3.2 Viruses: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parasite
- 8.4.1 Overview
- 8.4.2 Parasite: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Microbiology CRO Market Analysis - by End User

9.1 Biotech and Pharmaceutical Companies
- 9.1.1 Overview
- 9.1.2 Biotech and Pharmaceutical Companies: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Medical Device Companies
- 9.2.1 Overview
- 9.2.2 Medical Device Companies: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Microbiology CRO Market - Country Analysis

10.1 South and Central America
- 10.1.1 South & Central America Microbiology CRO Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 South & Central America Microbiology CRO Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Brazil: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Brazil: South & Central America Microbiology CRO Market Share - by Application
    - 10.1.1.2.2 Brazil: South & Central America Microbiology CRO Market Share - by Clinical
    - 10.1.1.2.3 Brazil: South & Central America Microbiology CRO Market Share - by Infectious Diseases
    - 10.1.1.2.4 Brazil: South & Central America Microbiology CRO Market Share - by Service Type
    - 10.1.1.2.5 Brazil: South & Central America Microbiology CRO Market Share - by Microbial Testing
    - 10.1.1.2.6 Brazil: South & Central America Microbiology CRO Market Share - by Microorganisms
    - 10.1.1.2.7 Brazil: South & Central America Microbiology CRO Market Share - by End User
  - 10.1.1.3 Argentina: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Argentina: South & Central America Microbiology CRO Market Share - by Application
    - 10.1.1.3.2 Argentina: South & Central America Microbiology CRO Market Share - by Clinical
    - 10.1.1.3.3 Argentina: South & Central America Microbiology CRO Market Share - by Infectious Diseases
    - 10.1.1.3.4 Argentina: South & Central America Microbiology CRO Market Share - by Service Type
    - 10.1.1.3.5 Argentina: South & Central America Microbiology CRO Market Share - by Microbial Testing
    - 10.1.1.3.6 Argentina: South & Central America Microbiology CRO Market Share - by Microorganisms
    - 10.1.1.3.7 Argentina: South & Central America Microbiology CRO Market Share - by End User
  - 10.1.1.4 Rest of South and Central America: South & Central America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Rest of South and Central America: South & Central America Microbiology CRO Market Share - by Application
    - 10.1.1.4.2 Rest of South and Central America: South & Central America Microbiology CRO Market Share - by Clinical
    - 10.1.1.4.3 Rest of South and Central America: South & Central America Microbiology CRO Market Share - by Infectious Diseases
    - 10.1.1.4.4 Rest of South and Central America: South & Central America Microbiology CRO Market Share - by Service Type
    - 10.1.1.4.5 Rest of South and Central America: South & Central America Microbiology CRO Market Share - by Microbial Testing
    - 10.1.1.4.6 Rest of South and Central America: South & Central America Microbiology CRO Market Share - by Microorganisms
    - 10.1.1.4.7 Rest of South and Central America: South & Central America Microbiology CRO Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Microbiology CRO Services Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Microbiologics
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Melbec Microbiology
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Emery Pharma
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 TheraIndx Lifesciences Pvt. Ltd.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 AVERIN BIOTECH
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Statens Serum Institut
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ImQuest BioSciences
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 PACIFIC BIOLABS
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Innovotech Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 BluTest Laboratories Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 List of Abbreviations